Anatomic
Anatomic is a Minneapolis biotech (founded 2018) that sells hiPSC-derived neural cells, differentiation kits, and custom services to academic and pharma researchers, using a proprietary protocol that accelerates neuron production to roughly 7 days versus conventional ~1 month timelines.
- Company typePrivate
- Founded2018
- HeadquartersMinneapolis, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
Anatomic firmographics
Firmographics- Name
- Anatomic
- Legal name
- Anatomic Incorporated
- Website
- https://anatomic.tech
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Anatomic is a Minneapolis biotech (founded 2018) that sells hiPSC-derived neural cells, differentiation kits, and custom services to academic and pharma researchers, using a proprietary protocol that accelerates neuron production to roughly 7 days versus conventional ~1 month timelines.
- Ownership category
- akta.pro rank
Anatomic industry classification
Industry- Product category
- Stem Cell Research Products
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)
Keywords
Where Anatomic is headquartered
LocationHeadquarters
- HQ city
- Minneapolis
- HQ country
- United States
- HQ region
- North America
Markets served
Anatomic business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Revenue model
- Cryopreserved hiPSC-Derived Cells: Sale of off-the-shelf cryopreserved human iPSC-derived neural cells including Sensory Neurons, Motor Neurons, Schwann Cell Precursors, Melanocytes, and Dorsal Horn Neurons for immediate use by researchers.
- Differentiation Kits: Human pluripotent stem cell differentiation medium for the rapid manufacture of various neural cell types. Products include Sensory Neuron, Motor Neuron, Schwann Cell Precursor, and Melanocyte differentiation kits.
- Custom Differentiation Services: Bespoke cell differentiation services delivering specific neural cell types with rapid 6-8 week turnaround time. Provides Schwann cells, motor neurons, sensory neurons, melanocytes, and dorsal horn neurons to customer specifications.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
Anatomic product offering
Product offeringCore offering
Anatomic is a biotechnology company that develops and sells cryopreserved human induced pluripotent stem cell (hiPSC)-derived neural cells and differentiation kits, including sensory neurons, motor neurons, Schwann cell precursors, melanocytes, and dorsal horn neurons, for use by academic and pharmaceutical researchers in basic science and drug discovery. Its proprietary differentiation platform produces Primal Ectoderm within 24 hours and immature neurons within seven days, cutting traditional manufacturing timelines by roughly 75%. The company also offers custom differentiation services with a 6–8 week turnaround for researchers requiring bespoke cell production.
Product overview
Anatomic is a biotech company offering a dual-product portfolio focused on accelerated production of hiPSC-derived neurons and related cell types. The portfolio consists of cryopreserved cells (ready-to-use off-the-shelf products including Sensory Neurons, Motor Neurons, Schwann Cell Precursors, Melanocytes, and Dorsal Horn Neurons) paired with differentiation kits that enable researchers to rapidly manufacture these same cell types from human pluripotent stem cells. Anatomic's proprietary technology platform produces Primal Ectoderm within 24 hours and generates immature neurons within seven days—compared to the traditional one-month timeline—creating a shortcut to patterning stages important for neuronal diversity. The company also offers custom differentiation services with a 6-8 week turnaround for researchers requiring bespoke cell production.
Differentiator
Problem solved
Functional benefit
Products and services
- Sensory Neurons (Cryopreserved)
Quantifiable outcome
- Neuron production time reduced from 1 month to 1 week (75% reduction)
- +2 more outcomes
Companies that use Anatomic
Customer profileSegments2 records
Ideal customer profiles2 records
Anatomic technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Anatomic partnerships and signals
Strategic signalRecent moves5 records
Expansion highlights5 records
Anatomic competitors and assessment
Company assessmentDirect peers
- BrainXell: BrainXell specializes in the differentiation of hiPSCs into neural cell types, including motor neurons and dopaminergic neurons, for research and drug discovery. It is a direct competitor to Anatomic in the hiPSC-derived neural cell market, targeting overlapping academic and pharma customers.
- Axol Bioscience: Axol Bioscience produces iPSC-derived neural cells, including sensory neurons, motor neurons, and astrocytes, for research and drug discovery applications. It directly competes with Anatomic across the same customer segments and product categories.
- Ncardia: Ncardia develops iPSC-derived cell products and services for drug discovery and cell therapy development, with a strong focus on neural and cardiac cell types. It is a direct peer in the iPSC-derived cell products and custom services market.
Broad incumbents
- FujiFilm Cellular Dynamics: Cellular Dynamics (a FujiFilm subsidiary) is a leading provider of iPSC-derived cells, including neural cell types, for research, drug discovery, and clinical applications. It is a broad incumbent that overlaps with Anatomic's neural cell product line but operates at significantly greater scale.
- STEMCELL Technologies: STEMCELL Technologies is a major supplier of cell culture media, reagents, and differentiation kits, including products for neural cell differentiation. It competes with Anatomic's differentiation kit product line as a broad life science tools incumbent.
- Reprocell: Reprocell provides iPSC-derived cell products, reagents, and services for drug discovery and research. It competes with Anatomic in the broader iPSC-derived neural and other cell type markets with a wider product portfolio.
Emerging players
- bit.bio: bit.bio has developed a proprietary iPSC reprogramming technology (opti-ox) for the rapid generation of human cell types, including neural cells. It represents an emerging competitive threat in the accelerated iPSC differentiation space that Anatomic occupies.
- NeuCyte: NeuCyte develops iPSC-derived neural cell models and assays for neuroscience drug discovery. It overlaps with Anatomic's neural cell and custom service offerings, particularly for pharma/biotech drug screening applications.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Anatomic social profiles
Digital presenceAnatomic financial estimates
Financial estimateRevenue estimate
Valuation estimate
Anatomic leadership team
Management profileNumber of profiles
Anatomic funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Anatomic M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Anatomic
What does Anatomic do?
Anatomic is a biotechnology company that develops and sells cryopreserved human induced pluripotent stem cell (hiPSC)-derived neural cells and differentiation kits, including sensory neurons, motor neurons, Schwann cell precursors, melanocytes, and dorsal horn neurons, for use by academic and pharmaceutical researchers in basic science and drug discovery. Its proprietary differentiation platform produces Primal Ectoderm within 24 hours and immature neurons within seven days, cutting traditional manufacturing timelines by roughly 75%. The company also offers custom differentiation services with a 6–8 week turnaround for researchers requiring bespoke cell production.
Is Anatomic a public or private company?
Anatomic is a private company. It is classified as unknown and is currently operating.
When was Anatomic founded?
Anatomic was founded in 2018. It employs 1 to 10 people.
Where is Anatomic based?
Anatomic is headquartered in Minneapolis, United States, in the North America region.
How does Anatomic make money?
Three revenue lines are on record. Cryopreserved hiPSC-Derived Cells are the primary driver. The others are differentiation Kits and custom Differentiation Services.
Who are Anatomic's main competitors?
Direct peers on record are BrainXell, Axol Bioscience and Ncardia. Broad incumbents are FujiFilm Cellular Dynamics, STEMCELL Technologies and Reprocell. Emerging players are bit.bio and NeuCyte.
Does Anatomic have an API?
No public API is recorded for Anatomic.
What industry is Anatomic in?
Anatomic's product category is Stem Cell Research Products. Its primary akta.pro industry code is HLAAAMAL, Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls). Its NAICS code is 541714 and its SIC code is 2835.